SEI Investments’s Cymabay Therapeutics CBAY Stock Holding History

SEI Investments’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-70,972	Closed	-$1.68M	–	2725
2023 Q4	$1.68M	Sell	70,972 -13,448	-16%	-$240K	﹤0.01%	1681
2023 Q3	$1.26M	Buy	84,420 +28,545	+51%	+$378K	﹤0.01%	1808
2023 Q2	$612K	Buy	+55,875	New	+$520K	﹤0.01%	2058
2020 Q2	–	Sell	-62,875	Closed	-$93K	–	2462
2020 Q1	$93K	Hold	62,875	–	–	﹤0.01%	2264
2019 Q4	$123K	Buy	+62,875	New	+$236K	﹤0.01%	2324

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SEI Investments's CBAY Position: Q1 2024 in Review

SEI Investments sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 70,972 shares — an estimated $1.68M sold.

SEI Investments first reported a position in CBAY in Q4 2019 and held it in 5 quarters. The position peaked at $1.68M in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

SEI Investments reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
SEI Investments sold 70,972 Cymabay Therapeutics shares in Q1 2024, an estimated $1.68M.
SEI Investments first reported a position in Cymabay Therapeutics in Q4 2019 and held it in 5 quarters.
SEI Investments's Cymabay Therapeutics position peaked at $1.68M in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on SEI Investments's 13F filing for Q1 2024, filed 7 May 2024.